Search Results
Aug 07, 2026, 10:05 ET Pharming Group (PHAR) Securities Investigation Notice - Levi & Korsinsky
eligible to participate in the PHAR investigation?A: Investors who purchased PHAR stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares.Q: What do PHAR investors need to do right
More news about: Levi & Korsinsky, LLP
Aug 03, 2026, 10:07 ET PHAR SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Pharming Group
eligible to participate in the PHAR investigation?A: Investors who purchased PHAR stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares.Q: What do PHAR investors need to do right
More news about: SueWallSt.com
Jul 31, 2026, 16:58 ET Pharming Group Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Pharming Group (PHAR)
www.zlk.comFrequently Asked Questions About the PHAR InvestigationQ: Who is eligible to participate in the PHAR investigation?A: Investors who purchased Pharming Group (PHAR) stock or securities and suffered financial losses may be eligible. Eligibility is
More news about: Levi & Korsinsky, LLP
Jun 26, 2026, 12:24 ET Cadena de Vida Saludable: innovaciones en la cadena de suministro global de atención médica
cultivo hasta la taza.Mientras tanto, las marcas chinas de medicina tradicional china y bienestar están acelerando su expansión global. Guangzhou Phar. Holdings está creando ecosistemas industriales en el extranjero, mientras que Xin Bao Tang y Zhendong Pharmaceutical están integrando verticalmente
More news about: China International Supply Chain Expo
Jun 26, 2026, 12:18 ET Die 4. International Supply Chain Expo in China: Healthy Life Chain präsentiert das gesamte Spektrum globaler Innovationen in der Gesundheitsversorgungskette
beschleunigen chinesische Marken für traditionelle chinesische Medizin (TCM) und traditionelle Wellness-Produkte ihre globale Expansion. Guangzhou Phar. Holdings baut industrielle Ökosysteme im Ausland auf, während Xin Bao Tang und Zhendong Pharmaceutical die gesamte Lieferkette für authentische Kräuter
More news about: China International Supply Chain Expo
Jun 26, 2026, 12:10 ET 第4回中国国際サプライチェーン博覧会：「ヘルシーライフ・チェーン」が、グローバルなヘルスケア・サプライチェーンにおけるイノベーションの全容を披露
イチェーンを雲南省のコーヒー農園と直接結びつけ、持続可能な方法で調達されたコーヒー豆について、「土壌からカップまで」の完全なトレーサビリティを実現しています。一方、中国伝統医学（TCM）やヘリテージ・ウェルネス・ブランドは、世界的な事業拡大を加速させています。Guangzhou Phar. Holdingsは海外で産業エコシステムを構築している一方、Xin Bao TangとZhendong Pharmaceuticalは、本格的なハーブのサプライチェーン全体を垂直統合しています。このほか、 スマート脈診デバイスやインテリジェント灸治療装置など、AIを活用した次世代の診断ツールも
More news about: China International Supply Chain Expo
Jun 26, 2026, 04:33 ET 제4회 중국국제공급망엑스포: 건강 생활 체인, 글로벌 헬스케어 공급망 혁신의 전 스펙트럼 공개
윈난성 커피 농장과 직접 연결해 토양부터 컵에 이르기까지 지속 가능한 방식으로 조달된 원두의 완전한 추적 가능성을 구현하고 있다.한편, 중국 전통 의학(TCM) 및 전통 웰니스 브랜드들은 글로벌 확장을 가속화하고 있다. 광저우 파 홀딩스(Guangzhou Phar. Holdings)는 해외 산업 생태계를 구축하고 있으며, 신바오탕(Xin Bao Tang)과 전둥제약(Zhendong Pharmaceutical)은 정통 약초의 전체 공급망을 수직 통합하고 있다. 스마트 맥진 기기와 지능형 뜸 기기를 포함한 AI 기반 진단 도구의
More news about: China International Supply Chain Expo
Jun 25, 2026, 16:10 ET The 4th China International Supply Chain Expo: Healthy Life Chain Unveils Full Spectrum of Global Healthcare Supply Chain Innovation
sustainably sourced beans—from soil to cup.Meanwhile, Chinese TCM and heritage wellness brands are accelerating their global expansion. Guangzhou Phar. Holdings is building overseas industrial ecosystems, while Xin Bao Tang and Zhendong Pharmaceutical are vertically integrating the entire supply chain
More news about: China International Supply Chain Expo
Jun 25, 2026, 15:28 ET The 4th China International Supply Chain Expo: Healthy Life Chain Unveils Full Spectrum of Global Healthcare Supply Chain Innovation
sustainably sourced beans—from soil to cup.Meanwhile, Chinese TCM and heritage wellness brands are accelerating their global expansion. Guangzhou Phar. Holdings is building overseas industrial ecosystems, while Xin Bao Tang and Zhendong Pharmaceutical are vertically integrating the entire supply chain
More news about: China International Supply Chain Expo
Feb 26, 2026, 15:01 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR
2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Pharming Group N.V. ("Pharming" or the "Company") (NASDAQ: PHAR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980,
More news about: Pomerantz LLP
Feb 19, 2026, 20:04 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR
2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Pharming Group N.V. ("Pharming" or the "Company") (NASDAQ: PHAR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980,
More news about: Pomerantz LLP
Feb 12, 2026, 18:42 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR
2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Pharming Group N.V. ("Pharming" or the "Company") (NASDAQ: PHAR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980,
More news about: Pomerantz LLP
Feb 05, 2026, 21:53 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR
2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Pharming Group N.V. ("Pharming" or the "Company") (NASDAQ: PHAR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980,
More news about: Pomerantz LLP
Jan 22, 2026, 05:00 ET New Breast Cancer Therapy to Reduce Risk of Recurrence and Improve Disease-Free Survival Now Available in Thailand
https://pertento.fda.moph.go.th/FDA_INFORMATION_DRUG/Home/Phar_Product_Inform_Page?Newcode=U1DR1C1012671509711C [Accessed Dec 2025].2. Martin M, et al.
More news about: Specialised Therapeutics